Aclaris Therapeutics Inc (ACRS)
SG&A Expense Growth
-1.04%
Fiscal year · Period ending:
ACRS SG&A Expense Growth
Latest reported-1.04%period ending
Latest reported-1.04%period ending
ACRS FY SG&A Growth (YoY) (0.00% → -1.04%)
Latest values, visible window
High-resolution chart · PNG
ACRS sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -1.0404% | |
| -28.6031% | |
| 23.7337% | |
| 6.4101% | |
| 15.0463% | |
| -26.2227% | |
| -63.2142% | |
| 128.4756% | |
| 119.3957% | |
| 183.2395% | |
| 162.9812% | |
| 14.528% | |
| 0% |